Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

PharmacoEconomics / Springer


0.14

Impact Factor

0.17

5-Years IF

8

5-Years H index

Main indicators


Raw data


IF AIF IF5 DOC CDO CCU CIF CIT D2Y C2Y D5Y C5Y %SC CiY II AII
19900.1000 (%)0.04
19910.09000 (%)0.04
19920.09000 (%)0.04
19930.11000 (%)0.05
19940.12000 (%)0.04
19950.2000 (%)0.07
19960.23000 (%)0.09
19970.271010500 (%)0.09
19980.28122221010 (%)0.1
19990.322240.182222 (%)0.13
20000.390.0593110.031122211 (100%)0.15
20010.39334931 (%)0.14
20020.41341234 (%)0.18
20030.4353910.031324 (%)0.18
20040.4814010.032517 (%)0.2
20050.5274710.022618 (%)0.2
20060.50.066210920.023781613 (8.1%)0.2
20070.030.440.033814730.02146927521 (7.1%)0.18
20080.010.480.012216910.015810011131 (%)0.2
20090.490.012819720.0186013011 (12.5%)0.19
20100.10.470.0633230100.041550515791 (6.7%)0.17
20110.030.50.033226280.033961218365 (12.8%)20.060.19
20120.090.530.0887349200.0635656153134 (11.4%)10.010.19
20130.110.610.196445380.09139119132022170 (50.4%)80.080.21
20140.150.620.13123568860.15117183282763612 (10.3%)200.160.21
20150.260.650.21056731170.1757219563717511 (19.3%)110.10.2
20160.230.760.221458181370.173222852443988 (25%)70.050.22
20170.140.940.17999171530.1717250355569713 (76.5%)130.130.27
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
IF5: Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CCU: Cumulative number of citations to papers published until year y
CIF: Cumulative impact factor
CIT: Number of citations to papers published in year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y

 

50 most cited documents in this series:


#YearTitleCited
12013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

94
22008Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677.

Full description at Econpapers || Download paper

44
32014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

19
4Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

Full description at Econpapers || Download paper

19
52014Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43.

Full description at Econpapers || Download paper

14
62014Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Moro, Domenico ; Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902.

Full description at Econpapers || Download paper

13
72014Japan’s monetary policy in a challenging environment. (2014). Shirai, Sayuri . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24.

Full description at Econpapers || Download paper

12
82014Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Akcelik, Yasin ; Taskin, Temel ; Ermisoglu, Ergun . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:71-79.

Full description at Econpapers || Download paper

11
92015Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Cawley, John ; Biener, Adam ; Hammer, Mette ; Wintfeld, Neil . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722.

Full description at Econpapers || Download paper

8
102006Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003. (2006). Liu, Chien-Hsiang ; Lee, Yue-Chune ; Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902.

Full description at Econpapers || Download paper

8
112014Preferences for Oral Anticoagulants in Atrial Fibrillation: a Best–Best Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127.

Full description at Econpapers || Download paper

6
122014Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Neasham, David ; Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365.

Full description at Econpapers || Download paper

6
132014The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86.

Full description at Econpapers || Download paper

6
142012Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7. (2012). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:197-211.

Full description at Econpapers || Download paper

6
152015Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Nilsson, Fredrik ; Arnberg, Karl . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236.

Full description at Econpapers || Download paper

6
16Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Benedict, Agnes ; Muszbek, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675.

Full description at Econpapers || Download paper

6
172013Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. (2013). Boer, Anthonius ; Franken, Margreet ; Koopmanschap, Marc ; Nilsson, Fredrik ; Sandmann, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:9:p:781-797.

Full description at Econpapers || Download paper

5
182015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian ; Crausaz, Steffan ; Clement, Fiona . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924.

Full description at Econpapers || Download paper

5
192012Does the EQ-5D Reflect Lost Earnings?. (2012). van Exel, Job ; Tsuchiya, Aki ; Brouwer, Werner ; Kro, Marieke ; Brazier, John ; Tilling, Carl . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:1:p:47-61.

Full description at Econpapers || Download paper

5
202013How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119.

Full description at Econpapers || Download paper

5
212006The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003. (2006). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:3:p:5-25.

Full description at Econpapers || Download paper

5
222011Do Productivity Costs Matter?. (2011). Brouwer, Werner ; Papenburg, Joce ; Krol, Marieke ; Koopmanschap, Marc . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:601-619.

Full description at Econpapers || Download paper

5
232015Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework. (2015). McCabe, Christopher ; Stafinski, Tania ; Paulden, Mike ; Menon, Devidas . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:3:p:255-269.

Full description at Econpapers || Download paper

5
242014Self-employment against employment or unemployment: Markov transitions across the business cycle. (2014). Constant, Amelie ; Zimmermann, Klaus. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:51-87.

Full description at Econpapers || Download paper

5
252014Hedging China’s energy oil market risks. (2014). Lau, Marco ; Zhang, Zhe ; Tan, Na. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:99-112.

Full description at Econpapers || Download paper

4
262017A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models. (2017). Brazier, John ; Chevrou-Severac, Helene ; Rowen, Donna ; Ara, Roberta. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0545-x.

Full description at Econpapers || Download paper

4
272006The Value of Thinly Spread QALYs. (2006). Mortimer, Duncan. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:845-853.

Full description at Econpapers || Download paper

4
282010International Comparison of Comparative Effectiveness Research in Five Jurisdictions. (2010). Levy, Adrian ; Johnston, Karissa ; Mitton, Craig ; Harrigan, Brian ; Briggs, Andrew. In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:10:p:813-830.

Full description at Econpapers || Download paper

4
292006Generic Health-Related Quality-of-Life Assessment in Children and Adolescents. (2006). Nickel, Jennifer ; Ravens-Sieberer, Ulrike ; Wetzel, Ralf ; Wille, Nora ; Bullinger, Monika ; Erhart, Michael . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:12:p:1199-1220.

Full description at Econpapers || Download paper

4
302012Common Drug Review Recommendations. (2012). Rocchi, Angela ; Goeree, Ron ; Hopkins, Robert ; Miller, Elizabeth. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:229-246.

Full description at Econpapers || Download paper

4
312006Costs of Inflammatory Bowel Disease in Germany. (2006). Leidl, Reiner ; Konig, Hans-Helmut ; Stark, Renee . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:8:p:797-814.

Full description at Econpapers || Download paper

4
322013The Determinants of Cost-Effectiveness Potential: An Historical Perspective on Lipid-Lowering Therapies. (2013). Miraldo, Marisa ; McGrath, Clare ; Camejo, Rodrigo Refoios . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:445-454.

Full description at Econpapers || Download paper

4
332016Pharmaceutical Price Schemes in Europe: Time for a ‘Continental’ One?. (2016). Curto, Alessandro ; Freemantle, Nick ; Garattini, Livio. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0377-5.

Full description at Econpapers || Download paper

4
342014The probability of default in Russian banking. (2014). Karminsky, Alexander ; Kostrov, Alexander . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:81-98.

Full description at Econpapers || Download paper

4
352008Generic Entry, Reformulations and Promotion of SSRIs in the US. (2008). Koss, Catherine ; Frank, Richard ; Donohue, Julie ; Huskamp, Haiden ; Berndt, Ernst . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:603-616.

Full description at Econpapers || Download paper

4
362014Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965.

Full description at Econpapers || Download paper

4
371997Guidelines for Pharmacoeconomic Studies. (1997). Russell, Louise ; Luce, Bryan ; Weinstein, Milton ; Gold, Marthe ; Siegel, Joanna ; Torrance, George . In: PharmacoEconomics. RePEc:spr:pharme:v:11:y:1997:i:2:p:159-168.

Full description at Econpapers || Download paper

4
382015The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Seuring, Till ; Suhrcke, Marc ; Archangelidi, Olga . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831.

Full description at Econpapers || Download paper

4
392012Cost of Illness of Cystic Fibrosis in Germany. (2012). Schreyögg, Jonas ; Staab, Doris ; Tiemann, Oliver ; Heimeshoff, Mareike ; Schreyogg, Jonas ; Hollmeyer, Helge . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:9:p:763-777.

Full description at Econpapers || Download paper

3
402011Availability of and Access to Orphan Drugs. (2011). Stargardt, Tom ; Schreyögg, Jonas ; Blankart, Carl ; Schreyogg, Jonas. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:63-82.

Full description at Econpapers || Download paper

3
412013Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10.

Full description at Econpapers || Download paper

3
422008Assessing the Impact of Global Price Interdependencies. (2008). Richter, Anke . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:649-659.

Full description at Econpapers || Download paper

3
432015A Review and Classification of Approaches for Dealing with Uncertainty in Multi-Criteria Decision Analysis for Healthcare Decisions. (2015). Ijzerman, Maarten ; Broekhuizen, Henk ; Groothuis-Oudshoorn, Catharina ; Til, Janine ; Hummel, J.. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:5:p:445-455.

Full description at Econpapers || Download paper

3
442011Does the Market Share of Generic Medicines Influence the Price Level?. (2011). Dylst, Pieter ; Simoens, Steven . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:10:p:875-882.

Full description at Econpapers || Download paper

3
452014A Comparative Analysis of Two Contrasting European Approaches for Rewarding the Value Added by Drugs for Cancer: England Versus France. (2014). Jones, Elizabeth ; Drummond, Michael ; Haig, Jennifer ; Cawston, Helene ; Saba, Grece ; Pouvourville, Gerard . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:5:p:509-520.

Full description at Econpapers || Download paper

3
462015The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration. (2015). Gray, Alastair ; Froud, Robert ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver ; Petrou, Stavros . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:993-1011.

Full description at Econpapers || Download paper

3
472014Solo self-employed versus employer entrepreneurs: determinants and macro-economic effects in OECD countries. (2014). Stel, Andre ; Wennekers, Sander ; Scholman, Gerard . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:107-136.

Full description at Econpapers || Download paper

3
482010An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions. (2010). Devlin, Nancy ; ONeill, Phill . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:11:p:987-993.

Full description at Econpapers || Download paper

3
492014How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344.

Full description at Econpapers || Download paper

3
502014Capital’s grabbing hand? A cross-industry analysis of the decline of the labor share in OECD countries. (2014). Bassanini, Andrea ; Manfredi, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-30.

Full description at Econpapers || Download paper

3

50 most relevant documents in this series (papers most cited in the last two years)


#YearTitleCited
12013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

53
22008Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677.

Full description at Econpapers || Download paper

17
32014Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Moro, Domenico ; Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902.

Full description at Econpapers || Download paper

13
42014Preferences for Oral Anticoagulants in Atrial Fibrillation: a Best–Best Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127.

Full description at Econpapers || Download paper

6
52014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

6
62014Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43.

Full description at Econpapers || Download paper

6
72015Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Nilsson, Fredrik ; Arnberg, Karl . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236.

Full description at Econpapers || Download paper

6
82015Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework. (2015). McCabe, Christopher ; Stafinski, Tania ; Paulden, Mike ; Menon, Devidas . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:3:p:255-269.

Full description at Econpapers || Download paper

5
92014Self-employment against employment or unemployment: Markov transitions across the business cycle. (2014). Constant, Amelie ; Zimmermann, Klaus. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:51-87.

Full description at Econpapers || Download paper

5
102014The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86.

Full description at Econpapers || Download paper

5
112015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian ; Crausaz, Steffan ; Clement, Fiona . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924.

Full description at Econpapers || Download paper

5
122014Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Neasham, David ; Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365.

Full description at Econpapers || Download paper

5
132017A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models. (2017). Brazier, John ; Chevrou-Severac, Helene ; Rowen, Donna ; Ara, Roberta. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0545-x.

Full description at Econpapers || Download paper

4
142016Pharmaceutical Price Schemes in Europe: Time for a ‘Continental’ One?. (2016). Curto, Alessandro ; Freemantle, Nick ; Garattini, Livio. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0377-5.

Full description at Econpapers || Download paper

4
152014The probability of default in Russian banking. (2014). Karminsky, Alexander ; Kostrov, Alexander . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:81-98.

Full description at Econpapers || Download paper

4
162014Japan’s monetary policy in a challenging environment. (2014). Shirai, Sayuri . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24.

Full description at Econpapers || Download paper

4
172015The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Seuring, Till ; Suhrcke, Marc ; Archangelidi, Olga . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831.

Full description at Econpapers || Download paper

4
182015Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Cawley, John ; Biener, Adam ; Hammer, Mette ; Wintfeld, Neil . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722.

Full description at Econpapers || Download paper

4
192014Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965.

Full description at Econpapers || Download paper

4
202013Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. (2013). Boer, Anthonius ; Franken, Margreet ; Koopmanschap, Marc ; Nilsson, Fredrik ; Sandmann, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:9:p:781-797.

Full description at Econpapers || Download paper

3
212014Capital’s grabbing hand? A cross-industry analysis of the decline of the labor share in OECD countries. (2014). Bassanini, Andrea ; Manfredi, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-30.

Full description at Econpapers || Download paper

3
222013How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119.

Full description at Econpapers || Download paper

3
232016Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment. (2016). Kanavos, Panos ; Angelis, Aris. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0370-z.

Full description at Econpapers || Download paper

3
242015A Review and Classification of Approaches for Dealing with Uncertainty in Multi-Criteria Decision Analysis for Healthcare Decisions. (2015). Ijzerman, Maarten ; Broekhuizen, Henk ; Groothuis-Oudshoorn, Catharina ; Til, Janine ; Hummel, J.. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:5:p:445-455.

Full description at Econpapers || Download paper

3
252011Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

Full description at Econpapers || Download paper

3
262016A Model-Based Economic Evaluation of Biologic and Non-Biologic Options for the Treatment of Adults with Moderately-to-Severely Active Ulcerative Colitis after the Failure of Conventional Therapy. (2016). Basarir, Hasan ; James, Marrissa Martyn-St ; Harvey, Rebecca ; Archer, Rachel ; Ren, Shijie ; Tappenden, Paul ; Stevens, John ; Lobo, Alan ; Hoque, Sami . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0409-9.

Full description at Econpapers || Download How Much Should the NHS Pay for a QALY?. (2013). Haycox, Alan. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:357-359.

Full description at Econpapers || Download paper

3
282014Hedging China’s energy oil market risks. (2014). Lau, Marco ; Zhang, Zhe ; Tan, Na. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:99-112.

Full description at Econpapers || Download paper

3
292017The Use of Mapping to Estimate Health State Utility Values. (2017). Ara, Roberta ; Mukuria, Clara ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0548-7.

Full description at Econpapers || Download paper

3
302008Generic Entry, Reformulations and Promotion of SSRIs in the US. (2008). Koss, Catherine ; Frank, Richard ; Donohue, Julie ; Huskamp, Haiden ; Berndt, Ernst . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:603-616.

Full description at Econpapers || Download paper

3
312016Realising the Value of Linked Data to Health Economic Analyses of Cancer Care: A Case Study of Cancer 2015. (2016). Lorgelly, Paula ; Knott, Rachel ; Doble, Brett . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:2:p:139-154.

Full description at Econpapers || Download paper

2
322015Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program. (2015). Saez-Benito, Loreto ; Benrimoj, Shalom ; Jodar-Sanchez, Francisco ; Malet-Larrea, Amaia ; Martin, Jose ; Garcia-Mochon, Leticia ; del Amo, Lopez M. ; Martinez-Martinez, Fernando ; Gastelurrutia-Garralda, Miguel ; Garcia-Cardenas, Victoria ; Sabater-Hernandez, Daniel . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:6:p:599-610.

Full description at Econpapers || Download The Impact of the Urban Resident Basic Medical Insurance on Health Services Utilisation in China. (2014). Chen, Gang ; Xu, Fei ; Liu, Gordon. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:3:p:277-292.

Full description at Econpapers || Download paper

2
342012Valuation of the Child Health Utility 9D Index. (2012). Stevens, Katherine. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:8:p:729-747.

Full description at Econpapers || Download paper

2
352010Financial Effects of Pharmaceutical Price Regulation on R&D Spending by EU versus US Firms. (2010). Vernon, John ; Golec, Joseph . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:8:p:615-628.

Full description at Econpapers || Download paper

2
362014How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344.

Full description at Econpapers || Download paper

2
372007Health Utilities Using the EQ-5D in Studies of Cancer. (2007). Pickard, A. ; Lin, Hsiang-Wen ; Wilke, Caitlyn ; Lloyd, Andrew . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:5:p:365-384.

Full description at Econpapers || Download paper

2
382015Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective. (2015). Wong, Ruth ; Simpson, Emma ; Davis, Sarah ; Thokala, Praveen ; Breeze, Penny ; Bryden, Peter . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1187-1194.

Full description at Econpapers || Download paper

2
392016EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1.

Full description at Econpapers || Download paper

2
402016Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial. (2016). Jamison, Dean T ; Kim, Jane J ; Verguet, Stephane. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0414-z.

Full description at Econpapers || Download paper

2
412013Influence of Pharmacogenomic Profiling Prior to Pharmaceutical Treatment in Metastatic Colorectal Cancer on Cost Effectiveness. (2013). Frank, Martin ; Mittendorf, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:3:p:215-228.

Full description at Econpapers || Download paper

2
422014Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Akcelik, Yasin ; Taskin, Temel ; Ermisoglu, Ergun . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:71-79.

Full description at Econpapers || Download paper

2
432013Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Benedict, Agnes ; Muszbek, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675.

Full description at Econpapers || Download paper

2
442015A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028.

Full description at Econpapers || Download paper

2
452012Does the EQ-5D Reflect Lost Earnings?. (2012). van Exel, Job ; Tsuchiya, Aki ; Brouwer, Werner ; Kro, Marieke ; Brazier, John ; Tilling, Carl . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:1:p:47-61.

Full description at Econpapers || Download paper

2
462013Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10.

Full description at Econpapers || Download paper

2
472013Patient Preferences for the Treatment of Type 2 Diabetes: A Scoping Review. (2013). Little, Emily ; Purnell, Tanjala ; Joy, Susan ; Maruthur, Nisa ; Bridges, John . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:10:p:877-892.

Full description at Econpapers || Download paper

2
482016Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease. (2016). Mortimer, Duncan ; Heeley, Emma ; Dalziel, Kim ; Schilling, Chris ; Chalmers, John ; Clarke, Philip. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:2:p:195-205.

Full description at Econpapers || Download paper

2
492016The Value of Medicines: A Crucial but Vague Concept. (2016). Antoanzas, Fernando ; Postma, Maarten ; Terkola, Robert . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:12:d:10.1007_s40273-016-0434-8.

Full description at Econpapers || Download paper

2
502014A Comparative Analysis of Two Contrasting European Approaches for Rewarding the Value Added by Drugs for Cancer: England Versus France. (2014). Jones, Elizabeth ; Drummond, Michael ; Haig, Jennifer ; Cawston, Helene ; Saba, Grece ; Pouvourville, Gerard . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:5:p:509-520.

Full description at Econpapers || Download paper

2

Citing documents used to compute impact factor 35:


YearTitle
2017Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis. (2017). Buchanan, James ; Schuh, Anna ; Taylor, Jenny C ; Robbe, Pauline ; Clifford, Ruth ; Wordsworth, Sarah . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:8:d:10.1007_s40273-017-0519-z.

Full description at Econpapers || Download paper

2017Access, use, and challenges of claims data analyses in Germany. (2017). Neubauer, Sarah ; Zeidler, Jan ; Klora, Mike ; Kreis, Kristine . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:5:d:10.1007_s10198-016-0849-3.

Full description at Econpapers || Download paper

2017The savings from the 2016-2020 Framework Agreement on the Supply and Pricing of Medicines in Ireland: which counterfactual?. (2017). Gorecki, Paul. In: MPRA Paper. RePEc:pra:mprapa:79481.

Full description at Econpapers || Download paper

2017Modelling multicriteria value interactions with Reasoning Maps. (2017). Oliveira, Monica D ; Rodrigues, Teresa C ; Montibeller, Gilberto ; Bana, Carlos A. In: European Journal of Operational Research. RePEc:eee:ejores:v:258:y:2017:i:3:p:1054-1071.

Full description at Econpapers || Download paper

2017Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework. (2017). Angelis, Aris ; Kanavos, Panos. In: Social Science & Medicine. RePEc:eee:socmed:v:188:y:2017:i:c:p:137-156.

Full description at Econpapers || Download paper

2017Values for the ICECAP-Supportive Care Measure (ICECAP-SCM) for use in economic evaluation at end of life. (2017). Huynh, Elisabeth ; Flynn, Terry ; Kinghorn, Philip ; Rose, John ; Coast, Joanna. In: Social Science & Medicine. RePEc:eee:socmed:v:189:y:2017:i:c:p:114-128.

Full description at Econpapers || Download paper

2017Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis. (2017). Shih, Ya-Chen ; Mullins, Daniel C ; Park, Yujin ; Udeze, Chukwukadibia ; Olson, Melvin ; Lecomte, Pascal ; Goto, Daisuke . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0505-5.

Full description at Econpapers || Download paper

2017Ecological predictors of health-related quality of life (HRQoL) among children from low-income families in South Korea. (2017). Baek, Suyon ; Park, Jiyoung. In: Children and Youth Services Review. RePEc:eee:cysrev:v:81:y:2017:i:c:p:238-245.

Full description at Econpapers || Download paper

2017Social and emotional wellbeing assessment instruments for use with Indigenous Australians: A critical review. (2017). Scuffham, Paul ; le Grande, M ; Brown, A ; Jackson, A C ; Kularatna, S ; Thompson, D R ; Ski, C F. In: Social Science & Medicine. RePEc:eee:socmed:v:187:y:2017:i:c:p:164-173.

Full description at Econpapers || Download paper

2017Economic evaluation of personalized medicine: a call for real-world data. (2017). Terkola, Robert ; Postma, Maarten ; Antoanzas, Fernando . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:9:d:10.1007_s10198-017-0890-x.

Full description at Econpapers || Download paper

2017What is the Normative Basis for Selecting the Measure of Average Preferences for Use in Social Choices?. (2017). Shah, Koonal ; Buckingham, K ; Devlin, N. In: Research Papers. RePEc:ohe:respap:001798.

Full description at Econpapers || Download paper

2017Market approval for drugs in the EU: time to change direction?. (2017). Curto, Alessandro ; Garattini, Livio ; de Vooren, Katelijne. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:8:d:10.1007_s10198-016-0863-5.

Full description at Econpapers || Download paper

2017Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk. (2017). Petrie, Dennis ; Jackson, Rod ; Kerr, Andrew ; Chalmers, John ; Clarke, Philip ; Mortimer, Duncan ; Knight, Josh ; Schilling, Chris . In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:12:p:1233-1239.

Full description at Econpapers || Download paper

2017Associations of Health-Related Quality of Life with Overall Quality of Life in the Patient Reported Outcomes Measurement Information System (PROMIS®) Project. (2017). Palimaru, Alina ; Hays, Ron D. In: Applied Research in Quality of Life. RePEc:spr:ariqol:v:12:y:2017:i:2:d:10.1007_s11482-017-9515-x.

Full description at Econpapers || Download paper

2017Replicating Health Economic Models: Firm Foundations or a House of Cards?. (2017). Bermejo, Inigo ; Youn, Ji-Hee ; Tappenden, Paul . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0553-x.

Full description at Econpapers || Download paper

2017Comment on “Replicating Health Economic Models: Firm Foundations or a House of Cards?”. (2017). McManus, Emma ; Sach, Tracey. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0576-3.

Full description at Econpapers || Download paper

2017Response to ‘Comment on “Replicating Health Economic Models: Firm Foundations or a House of Cards?”’. (2017). Bermejo, Inigo ; Youn, Ji-Hee ; Tappenden, Paul . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0574-5.

Full description at Econpapers || Download paper

2017Acceptable health and priority weighting: Discussing a reference-level approach using sufficientarian reasoning. (2017). van Exel, Job ; Brouwer, Werner ; Vromen, J J ; Wouters, S. In: Social Science & Medicine. RePEc:eee:socmed:v:181:y:2017:i:c:p:158-167.

Full description at Econpapers || Download paper

2017The evolution of the cancer formulary review in Canada: Can centralization improve the use of economic evaluation?. (2017). Wranik, Dominika W ; Levy, Adrian ; Hanson, Natasha ; Gambold, Liesl. In: International Journal of Health Planning and Management. RePEc:bla:ijhplm:v:32:y:2017:i:2:p:e232-e260.

Full description at Econpapers || Download paper

2017Applications of the Capability Approach in the Health Field: A Literature Review. (2017). Mitchell, Paul Mark ; Coast, Joanna ; Barton, Pelham M ; Roberts, Tracy E. In: Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement. RePEc:spr:soinre:v:133:y:2017:i:1:d:10.1007_s11205-016-1356-8.

Full description at Econpapers || Download paper

2017The place of DPP-4 inhibitors in the treatment algorithm of diabetes type 2: a systematic review of cost-effectiveness studies. (2017). Baptista, Alexandre ; Perelman, Julian ; Carneiro, Antonio Vaz ; Romano, Sonia ; Teixeira, Ines . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:8:d:10.1007_s10198-016-0837-7.

Full description at Econpapers || Download paper

2017Reporting error in weight and height among older adults: Implications for estimating healthcare costs. (2017). Cawley, John ; Kessler, Asia Sikora ; MacLean, Johanna Catherine. In: The Journal of the Economics of Ageing. RePEc:eee:joecag:v:9:y:2017:i:c:p:122-144.

Full description at Econpapers || Download paper

2017Parental misclassification of child overweight/obese status: The role of parental education and parental weight status. (2017). Cawley, John ; Cullinan, John. In: Economics & Human Biology. RePEc:eee:ehbiol:v:24:y:2017:i:c:p:92-103.

Full description at Econpapers || Download paper

2017Waist circumference, body mass index, and employment outcomes. (2017). Kinge, Jonas Minet . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:6:d:10.1007_s10198-016-0833-y.

Full description at Econpapers || Download paper

2017Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four Europ. (2017). Nicod, Elena . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:6:d:10.1007_s10198-016-0823-0.

Full description at Econpapers || Download paper

2017The bare necessities? A realist review of necessity argumentations used in health care coverage decisions. (2017). Kleinhout-Vliek, Tineke ; Boer, Bert ; de Bont, Antoinette . In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:7:p:731-744.

Full description at Econpapers || Download paper

2017A review of international coverage and pricing strategies for personalized medicine and orphan drugs. (2017). Degtiar, Irina. In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:12:p:1240-1248.

Full description at Econpapers || Download paper

2017Association between copayment, medication adherence and outcomes in the management of patients with diabetes and heart failure. (2017). Gourzoulidis, George ; Maniadakis, Nikolaos ; Parissis, John ; Giamouzis, Gregory ; Stafylas, Panagiotis ; Kourlaba, Georgia . In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:4:p:363-377.

Full description at Econpapers || Download paper

2017Economic Evaluation of Fulvestrant 500 mg Compared to Generic Aromatase Inhibitors in Patients with Advanced Breast Cancer in Sweden. (2017). Sabale, Ugne ; Livings, Christopher ; Telford, Claire ; Thunstrom, Daniel ; Ekman, Mattias . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0031-6.

Full description at Econpapers || Download paper

2017Drug Pricing in South Korea. (2017). Kwon, Hye-Young ; Godman, Brian . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:4:d:10.1007_s40258-017-0307-0.

Full description at Econpapers || Download paper

2017How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries. (2017). Vogler, Sabine ; Dedet, Guillaume ; Pedersen, Hanne Bak ; Schneider, Peter ; Joncheere, Kees ; Wirtz, Veronika J ; Ferrario, Alessandra ; Paris, Valerie . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:3:d:10.1007_s40258-016-0300-z.

Full description at Econpapers || Download paper

2017A relevance ranking method for citation-based search results. (2017). Belter, Christopher W. In: Scientometrics. RePEc:spr:scient:v:112:y:2017:i:2:d:10.1007_s11192-017-2406-y.

Full description at Econpapers || Download paper

2017Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?. (2017). Towse, Adrian ; Hampson, Grace ; Marsden, G. In: Consulting Reports. RePEc:ohe:conrep:001802.

Full description at Econpapers || Download paper

2017Cost analysis and cost-benefit analysis of a medication review with follow-up service in aged polypharmacy patients. (2017). Malet-Larrea, Amaia ; Benrimoj, Shalom I ; Sabater-Hernandez, Daniel ; Martinez-Martinez, Fernando ; Noain, Aranzazu ; Cabases, Juan M ; Garcia-Cardenas, Victoria ; Calvo, Begoa ; Gastelurrutia, Miguel A ; Goyenechea, Estibaliz. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:9:d:10.1007_s10198-016-0853-7.

Full description at Econpapers || Download Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges. (2017). Lamsal, Ramesh ; Zwicker, Jennifer D. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:6:d:10.1007_s40258-017-0343-9.

Full description at Econpapers || Download paper

Recent citations (cites in year: CiY)


Recent citations received in 2017

YearCiting document
2017Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges. (2017). Lamsal, Ramesh ; Zwicker, Jennifer D. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:6:d:10.1007_s40258-017-0343-9.

Full description at Econpapers || Download paper

2017Response to ‘Comment on “Replicating Health Economic Models: Firm Foundations or a House of Cards?”’. (2017). Bermejo, Inigo ; Youn, Ji-Hee ; Tappenden, Paul . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0574-5.

Full description at Econpapers || Download paper

2017Comment on “Replicating Health Economic Models: Firm Foundations or a House of Cards?”. (2017). McManus, Emma ; Sach, Tracey. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0576-3.

Full description at Econpapers || Download paper

2017Heath State Utility Values for Cost-Effectiveness Models. (2017). Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0537-x.

Full description at Econpapers || Download paper

2017The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment. (2017). Rowen, Donna ; Zouraq, Ismail Azzabi ; Ara, Roberta ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0546-9.

Full description at Econpapers || Download paper

2017The Identification, Review and Synthesis of Health State Utility Values from the Literature. (2017). Ara, Roberta ; Paisley, Suzy ; Peasgood, Tessa ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0547-8.

Full description at Econpapers || Download paper

2017The Use of Mapping to Estimate Health State Utility Values. (2017). Ara, Roberta ; Mukuria, Clara ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0548-7.

Full description at Econpapers || Download paper

2017Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies. (2017). Ara, Roberta ; Young, Tracey ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0549-6.

Full description at Econpapers || Download paper

2017The Use of Health State Utility Values in Decision Models. (2017). Ara, Roberta ; Zouraq, Ismail Azzabi ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0550-0.

Full description at Econpapers || Download paper

2017Making Implicit Assumptions Explicit in the Costing of Informal Care: The Case of Head and Neck Cancer in Ireland. (2017). Hanly, Paul ; Sharp, Linda ; Osullivan, Eleanor ; Balfe, Myles ; Maguire, Rebecca. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:5:d:10.1007_s40273-017-0490-8.

Full description at Econpapers || Download paper

2017Response to Letter to the Editor Regarding “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NI. (2017). , Bram ; Joore, Manuela A ; Kleijnen, Jos ; Severens, Johan L ; Armstrong, Nigel ; Duffy, Steven ; Deshpande, Sohan ; Asselt, Thea ; Tomini, Florian ; Riemsma, Rob . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:6:d:10.1007_s40273-017-0507-3.

Full description at Econpapers || Download An Investigation of the Overlap Between the ICECAP-A and Five Preference-Based Health-Related Quality of Life Instruments. (2017). Engel, Lidia ; David, ; Lear, Scott A ; Bryan, Stirling ; Mortimer, Duncan . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0491-7.

Full description at Econpapers || Download paper

2017Ahead of Our Time: Collaboration in Modeling Then and Now. (2017). , Renee ; Ekins, Sean . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0532-2.

Full description at Econpapers || Download paper

Recent citations received in 2016

YearCiting document
2016Fairer decisions, better health for all: Health equity and cost-effectiveness analysis. (2016). Asaria, Miqdad ; Mirelman, Andrew ; Cookson, Richard ; Griffin, Susan ; Dawkins, Bryony . In: Working Papers. RePEc:chy:respap:135cherp.

Full description at Econpapers || Download paper

2016Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations. (2016). Bugnon, Olivier ; Perraudin, Clemence ; Pelletier-Fleury, Nathalie . In: Health Policy. RePEc:eee:hepoli:v:120:y:2016:i:12:p:1350-1362.

Full description at Econpapers || Download paper

2016Limiting Free Pricing of New Innovative Drugs After Launch: A Necessity for Payers?. (2016). Gandjour, Afschin. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:14:y:2016:i:5:d:10.1007_s40258-016-0247-0.

Full description at Econpapers || Download paper

2016Reimbursable drug classes and ceilings in Italy: why not only one?. (2016). Padula, Anna ; Curto, Alessandro ; Garattini, Livio. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:17:y:2016:i:8:d:10.1007_s10198-016-0808-z.

Full description at Econpapers || Download paper

2016Big Data and Its Role in Health Economics and Outcomes Research: A Collection of Perspectives on Data Sources, Measurement, and Analysis. (2016). Onukwugha, Eberechukwu . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:2:d:10.1007_s40273-015-0378-4.

Full description at Econpapers || Download paper

2016Why Cancer?. (2016). Haycox, Alan . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0413-0.

Full description at Econpapers || Download paper

2016Model Validation: Has it’s Time Come?. (2016). Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0415-y.

Full description at Econpapers || Download paper

Recent citations received in 2015

YearCiting document
2015Neural Network Estimators of Binary Choice Processes: Estimation, Marginal Effects and WTP. (2015). Bergtold, Jason ; Ramsey, Steven M. In: 2015 AAEA & WAEA Joint Annual Meeting, July 26-28, San Francisco, California. RePEc:ags:aaea15:205649.

Full description at Econpapers || Download paper

2015Reporting error in weight and its implications for bias in economic models. (2015). Maclean, Johanna ; Cawley, John ; Hammer, Mette ; Wintfeld, Neil . In: Economics & Human Biology. RePEc:eee:ehbiol:v:19:y:2015:i:c:p:27-44.

Full description at Econpapers || Download paper

2015An economy of scales: A selective review of obesitys economic causes, consequences, and solutions. (2015). Cawley, John. In: Journal of Health Economics. RePEc:eee:jhecon:v:43:y:2015:i:c:p:244-268.

Full description at Econpapers || Download paper

2015Assessing sufficient capability: A new approach to economic evaluation. (2015). Mitchell, Paul Mark ; Coast, Joanna ; Barton, Pelham M ; Roberts, Tracy E. In: Social Science & Medicine. RePEc:eee:socmed:v:139:y:2015:i:c:p:71-79.

Full description at Econpapers || Download paper

2015Unpaid work in health economic evaluations. (2015). Brouwer, Werner ; Krol, Marieke . In: Social Science & Medicine. RePEc:eee:socmed:v:144:y:2015:i:c:p:127-137.

Full description at Econpapers || Download paper

2015Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. (2015). Gray, Alastair ; Petrou, Stavros ; Froud, Robert ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:13:y:2015:i:5:p:437-443.

Full description at Econpapers || Download paper

2015Is personalized medicine a panacea for health management? Some thoughts on its desirability. (2015). Rodriguez-Ibeas, Roberto ; Juarez-Castello, Carmelo ; Antoanzas, Fernando . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:16:y:2015:i:5:p:455-457.

Full description at Econpapers || Download paper

2015Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. (2015). Gray, Alastair ; Froud, Robert ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver ; Petrou, Stavros . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:985-991.

Full description at Econpapers || Download paper

2015For a Step Change to Curb the Obesity Epidemic. (2015). Cremieux, Pierre-Yves ; Frois, Christian . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:613-617.

Full description at Econpapers || Download paper

2015The Economic Burden of Obesity by Glycemic Stage in the United States. (2015). Li, Qian ; Graf, Thomas ; Hammer, Mette ; Huang, Joanna ; Blume, Steven . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:735-748.

Full description at Econpapers || Download paper

2015Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions. (2015). Frederix, Gerardus ; Ward, Robyn ; Dasbach, Erik ; Ali, Hossein Haji. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:777-781.

Full description at Econpapers || Download paper

Recent citations received in 2014

YearCiting document
2014Addressing elimination and selection by aspects decision rules in discrete choice experiments: does it matter?. (2014). Erdem, Seda ; Campbell, Danny ; Thompson, Carl . In: 2014 Annual Meeting, July 27-29, 2014, Minneapolis, Minnesota. RePEc:ags:aaea14:169839.

Full description at Econpapers || Download paper

2014Elimination and selection by aspects in health choice experiments: Prioritising health service innovations. (2014). Erdem, Seda ; Campbell, Danny ; Thompson, Carl . In: Journal of Health Economics. RePEc:eee:jhecon:v:38:y:2014:i:c:p:10-22.

Full description at Econpapers || Download paper

2014Global Entrepreneurship Monitor The Netherlands 2013. (2014). van Stel, André ; Span, Tommy ; Hessels, Jolanda. In: Scales Research Reports. RePEc:eim:papers:h201407.

Full description at Econpapers || Download paper

2014The Willingness to Pay for a QALY: a Review of the Empirical Literature. (2014). Svensson, Mikael ; Ryen, Linda . In: Karlstad University Working Papers in Economics. RePEc:hhs:kaunek:0012.

Full description at Econpapers || Download paper

2014Editorial Volume 7(3). (2014). Schofield, Deborah J ; Shrestha, Rupendra ; Carter, Hannah E. In: International Journal of Microsimulation. RePEc:ijm:journl:v:7:y:2014:i:3:p:33-52.

Full description at Econpapers || Download paper

2014Life at a premium: considering an end-of-life premium in Value Based Reimbursement.. (2014). Culyer, Anthony ; Edlin, Richard ; Paulden, Mike ; O'Mahony, James ; McCabe, Christopher . In: Working Papers. RePEc:lee:wpaper:1407.

Full description at Econpapers || Download paper

2014Monetary policy challenges: how central banks changed their modus operandi. (2014). Di Giorgio, Giorgio. In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:1:p:25-43.

Full description at Econpapers || Download paper

2014Japan’s monetary policy in a challenging environment. (2014). Shirai, Sayuri . In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:1:p:3-24.

Full description at Econpapers || Download paper

2014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Kilinc, Mustafa ; Fendoglu, Salih ; Aysan, Ahmet. In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

2014Effects of additional monetary tightening on exchange rates. (2014). Taskin, Temel ; Oduncu, Arif ; Ermisoglu, Ergun ; Akcelik, Yasin. In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:1:p:71-79.

Full description at Econpapers || Download paper

2014Hedging with mini gold futures: evidence from Korea. (2014). Park, Cheolho ; Yun, Youngjun . In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:2:p:163-176.

Full description at Econpapers || Download paper

2014Is health care expenditure across Europe converging? Findings from the application of a nonlinear panel unit root test. (2014). Lau, Chi ; Pugalis, Lee ; Fung, Ka. In: Eurasian Business Review. RePEc:spr:eurasi:v:4:y:2014:i:2:p:137-156.

Full description at Econpapers || Download paper

2014Patterns of innovation and wage distribution. Do “innovative firms” pay higher wages? Evidence from Chile. (2014). Cirillo, Valeria. In: Eurasian Business Review. RePEc:spr:eurasi:v:4:y:2014:i:2:p:181-206.

Full description at Econpapers || Download paper

2014Does Diabetes Have an Impact on Health-State Utility? A Study of Asians in Singapore. (2014). Tai, E. ; Wang, P. ; Luo, Nan ; Thumboo, J. ; Vrijhoef, Hubertus . In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:7:y:2014:i:3:p:329-337.

Full description at Econpapers || Download paper

2014Modelling Technique, Structural Assumptions, Input Parameter Values: Which Has the Most Impact on the Results of a Cost-Effectiveness Analysis?. (2014). Mauskopf, Josephine . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:6:p:521-523.

Full description at Econpapers || Download paper

2014Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation. (2014). Hagen, Gunhild ; Wisloff, Torbjorn ; Klemp, Marianne . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:6:p:601-612.

Full description at Econpapers || Download paper

2014Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43.

Full description at Econpapers || Download paper

2014Japan’s monetary policy in a challenging environment. (2014). Shirai, Sayuri . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24.

Full description at Econpapers || Download paper

2014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

2014Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Akcelik, Yasin ; Taskin, Temel ; Ermisoglu, Ergun . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:71-79.

Full description at Econpapers || Download paper

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated June, 2th 2018. Contact: CitEc Team